Literature DB >> 22965355

Genetic and epigenetic stability of human pluripotent stem cells.

Riikka J Lund1, Elisa Närvä, Riitta Lahesmaa.   

Abstract

Studies using high-resolution genome-wide approaches have recently reported that genomic and epigenomic alterations frequently accumulate in human pluripotent cells. Detailed characterization of these changes is crucial for understanding the impact of these alterations on self-renewal and proliferation, and particularly on the developmental and malignant potential of the cells. Such knowledge is required for the optimized and safe use of pluripotent cells for therapeutic purposes, such as regenerative cellular therapies using differentiated derivatives of pluripotent cells.In this Review, we summarize the current knowledge of the genomic and epigenomic stability of pluripotent human cells and the implications for stem cell research.

Entities:  

Mesh:

Year:  2012        PMID: 22965355     DOI: 10.1038/nrg3271

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  105 in total

1.  Derivation, characterization, and differentiation of human embryonic stem cells.

Authors:  Nico Heins; Mikael C O Englund; Cecilia Sjöblom; Ulf Dahl; Anna Tonning; Christina Bergh; Anders Lindahl; Charles Hanson; Henrik Semb
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 2.  Epigenetics and the environment: emerging patterns and implications.

Authors:  Robert Feil; Mario F Fraga
Journal:  Nat Rev Genet       Date:  2012-01-04       Impact factor: 53.242

3.  Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes.

Authors:  Walter D Funk; Ivan Labat; Janani Sampathkumar; Pierre-Antoine Gourraud; Jorge R Oksenberg; Elen Rosler; Daniel Steiger; Nadia Sheibani; Stacy Caillier; Birgit Stache-Crain; Julie A Johnson; Lorraine Meisner; Markus D Lacher; Karen B Chapman; Myung Jin Park; Kyoung-Jin Shin; Rade Drmanac; Michael D West
Journal:  Stem Cell Res       Date:  2011-10-08       Impact factor: 2.020

4.  Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines.

Authors:  Kee-Pyo Kim; Alexandra Thurston; Christine Mummery; Dorien Ward-van Oostwaard; Helen Priddle; Cinzia Allegrucci; Chris Denning; Lorraine Young
Journal:  Genome Res       Date:  2007-11-07       Impact factor: 9.043

5.  Recurrent chromosomal abnormalities in human embryonic stem cells.

Authors:  Claudia Spits; Ileana Mateizel; Mieke Geens; Afroditi Mertzanidou; Catherine Staessen; Yves Vandeskelde; Josiane Van der Elst; Inge Liebaers; Karen Sermon
Journal:  Nat Biotechnol       Date:  2008-11-23       Impact factor: 54.908

6.  Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations.

Authors:  Christopher J Lengner; Alexander A Gimelbrant; Jennifer A Erwin; Albert Wu Cheng; Matthew G Guenther; G Grant Welstead; Raaji Alagappan; Garrett M Frampton; Ping Xu; Julien Muffat; Sandro Santagata; Doug Powers; C Brent Barrett; Richard A Young; Jeannie T Lee; Rudolf Jaenisch; Maisam Mitalipova
Journal:  Cell       Date:  2010-05-13       Impact factor: 41.582

7.  Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells.

Authors:  Uri Ben-David; Yoav Mayshar; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

8.  Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.

Authors:  Aaron R Quinlan; Michael J Boland; Mitchell L Leibowitz; Svetlana Shumilina; Sidney M Pehrson; Kristin K Baldwin; Ira M Hall
Journal:  Cell Stem Cell       Date:  2011-10-04       Impact factor: 24.633

Review 9.  Genomic imprinting: the emergence of an epigenetic paradigm.

Authors:  Anne C Ferguson-Smith
Journal:  Nat Rev Genet       Date:  2011-07-18       Impact factor: 53.242

10.  An improved technique for chromosomal analysis of human ES and iPS cells.

Authors:  Daniela Moralli; Mohammed Yusuf; Mohammad A Mandegar; Suhail Khoja; Zoia L Monaco; Emanuela V Volpi
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

View more
  88 in total

Review 1.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

2.  Epigenetics, vitamin supplements and cellular reprogramming.

Authors:  Martin F Pera
Journal:  Nat Genet       Date:  2013-12       Impact factor: 38.330

Review 3.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

4.  The silver lining of induced pluripotent stem cell variation.

Authors:  Valentina Fossati; Tanya Jain; Ana Sevilla
Journal:  Stem Cell Investig       Date:  2016-12-06

Review 5.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

6.  Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles.

Authors:  Uri Ben-David; Yoav Mayshar; Nissim Benvenisty
Journal:  Nat Protoc       Date:  2013-04-25       Impact factor: 13.491

7.  Mutation frequency dynamics in HPRT locus in culture-adapted human embryonic stem cells and induced pluripotent stem cells correspond to their differentiated counterparts.

Authors:  Miriama Krutá; Monika Šeneklová; Jan Raška; Anton Salykin; Lenka Zerzánková; Martin Pešl; Eva Bártová; Michal Franek; Aneta Baumeisterová; Stanislava Košková; Kai J Neelsen; Aleš Hampl; Petr Dvořák; Vladimír Rotrekl
Journal:  Stem Cells Dev       Date:  2014-07-25       Impact factor: 3.272

Review 8.  Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.

Authors:  Patricia K Nguyen; Evgenios Neofytou; June-Wha Rhee; Joseph C Wu
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

9.  Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation.

Authors:  Hye-Yeong Jo; Youngsun Lee; Hongryul Ahn; Hyeong-Jun Han; Ara Kwon; Bo-Young Kim; Hye-Yeong Ha; Sang Cheol Kim; Jung-Hyun Kim; Yong-Ou Kim; Sun Kim; Soo Kyung Koo; Mi-Hyun Park
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

Review 10.  Genomic instability in pluripotent stem cells: implications for clinical applications.

Authors:  Suzanne E Peterson; Jeanne F Loring
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.